William Blair initiated coverage of Trupanion with a rating of Outperform
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/13/2025 | $47.00 | Neutral | Cantor Fitzgerald |
| 1/23/2025 | $57.00 | Neutral → Overweight | Piper Sandler |
| 7/19/2024 | Outperform | William Blair | |
| 5/16/2024 | $35.00 → $49.00 | Neutral → Buy | BofA Securities |
| 5/8/2023 | $72.00 → $32.00 | Buy → Neutral | BofA Securities |
| 9/21/2022 | $77.00 | Buy | Jefferies |
| 8/4/2022 | $80.00 → $69.00 | Overweight → Neutral | Piper Sandler |
| 2/24/2022 | $129.00 → $118.00 | Neutral → Buy | B of A Securities |
4/A - TRUPANION, INC. (0001371285) (Issuer)
4 - TRUPANION, INC. (0001371285) (Issuer)
After taking 20 years to reach its first $1 billion in paid claims, Trupanion surpassed $4 billion just 18 months after crossing $3 billion, highlighting the growing role of high-quality pet insurance in reducing barriers to care. SEATTLE, May 26, 2026 (GLOBE NEWSWIRE) -- When Lacy, a three-year-old Goldendoodle from Illinois, recently received medication to help manage her allergies, it meant more than relief from a chronic condition—it meant her family could focus on her comfort rather than the bill. Lacy enrolled with Trupanion, North America's leading pet medical insurer, when she was just two months old. By a year and a half, she was already receiving treatment for chronic allergi
SEATTLE, April 30, 2026 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the first quarter ended March 31, 2026. "The gap between the cost of veterinary care and what pet parents can reasonably plan for continues to widen," said Margi Tooth, Chief Executive Officer and President of Trupanion. "Trupanion is uniquely positioned to meet this moment. Fueled by strong, compounding growth in discretionary profit, we are investing with discipline to broaden our offering, strengthen our competitive positioning, expand choice, and create enduring value for pet parents, veterinarians, and sharehold
SEATTLE, April 27, 2026 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leader in medical insurance for cats and dogs, has published its 2025 annual shareholder letter from CEO and President, Margi Tooth. The letter is now available on the Company's Investor Relations website here. About Trupanion Trupanion is a leader in medical insurance for cats and dogs throughout the United States, Canada, and certain countries in Continental Europe with over 1,000,000 pets currently enrolled. For over two decades, Trupanion has given pet owners peace of mind so they can focus on their pet's recovery, not financial stress. Trupanion is committed to providing pet parents with the highest value i
8-K - TRUPANION, INC. (0001371285) (Filer)
10-Q - TRUPANION, INC. (0001371285) (Filer)
8-K - TRUPANION, INC. (0001371285) (Filer)
Cantor Fitzgerald initiated coverage of Trupanion with a rating of Neutral and set a new price target of $47.00
Piper Sandler upgraded Trupanion from Neutral to Overweight and set a new price target of $57.00
William Blair initiated coverage of Trupanion with a rating of Outperform
4/A - TRUPANION, INC. (0001371285) (Issuer)
4/A - TRUPANION, INC. (0001371285) (Issuer)
4 - TRUPANION, INC. (0001371285) (Issuer)
Cohen to serve as Chair of the Audit Committee Grindr Inc. (NYSE:GRND), the Global Gayborhood in Your Pocket™, today announced the appointment of Chad Cohen, former Chief Financial Officer of Zillow Group Inc. (NASDAQ:Z) and Adaptive Biotechnologies Corp. (NASDAQ:ADPT) and Founding Partner of Scala Advisors, LLC, to Grindr's Board of Directors as of June 3, 2025. Cohen was also appointed to serve as the Chair of Grindr's Audit Committee. A seasoned public company finance executive and board member, Cohen has helped grow several multi-billion dollar technology companies, including multiple leading consumer Internet brands. Prior to his current role, Cohen served as the Chief Financial Of
Boehringer Ingelheim, Mars Science & Diagnostics and leading pet, public health and animal health authorities to join Advisory Board Collaboration to address emerging pet and public health threats to protect pets and peopleEarly detection potential has global pet and public health benefits SEATTLE, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), the leading provider of medical insurance for cats and dogs in North America, in partnership with the Centers for Disease Control and Prevention (CDC), and leading pet industry partners, today announced the formation of a collaborative Advisory Board to launch a Pet & Public Health Early Warning & Detection System. The Advisory B
SEATTLE, May 02, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leading provider of medical insurance for cats and dogs, today announced that its Board of Directors has unanimously approved the appointment of Margi Tooth to Chief Executive Officer, effective August 1, 2024. Tooth's appointment to CEO marks the culmination of a multi-year, board-led process. Tooth will also continue as President and hold the dual titles of CEO and President. Additionally, Tooth is anticipated to be appointed to Trupanion's Board of Directors during its July meeting. Trupanion's founder and outgoing CEO Darryl Rawlings will continue to serve in the role of Chair of the Board, in which capacity he
SC 13G/A - TRUPANION, INC. (0001371285) (Subject)
SC 13G/A - TRUPANION, INC. (0001371285) (Subject)
SC 13G/A - TRUPANION, INC. (0001371285) (Subject)
SEATTLE, April 30, 2026 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the first quarter ended March 31, 2026. "The gap between the cost of veterinary care and what pet parents can reasonably plan for continues to widen," said Margi Tooth, Chief Executive Officer and President of Trupanion. "Trupanion is uniquely positioned to meet this moment. Fueled by strong, compounding growth in discretionary profit, we are investing with discipline to broaden our offering, strengthen our competitive positioning, expand choice, and create enduring value for pet parents, veterinarians, and sharehold
SEATTLE, April 16, 2026 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leader in medical insurance for cats and dogs, announced today it will report financial results for its 2026 first quarter after the market closes on Thursday, April 30, 2026. The company will host a conference call that day beginning shortly after 1:30 p.m. PT / 4:30 p.m. ET. A live webcast discussing results, guidance and management observations will be available on Trupanion's Investor Relations site under Investor Events at http://investors.trupanion.com and will be archived online for 3 months upon completion of the conference call. A slide presentation will also be available on the site. Participants can a
SEATTLE, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the fourth quarter and full year ended December 31, 2025. "Since 2021, we've delivered more than $500 million in discretionary profit, growing at a 22% CAGR, including over $150 million last year alone," said Margi Tooth, Chief Executive Officer and President of Trupanion. "In 2025, we achieved our 15% annual margin target, while increasing subscription revenue and reinvesting record profits to drive four straight quarters of higher retention and accelerating gross pet adds. We're poised to advance confidently into our n